ARMI is a member-based nonprofit institute that advances the U.S. bioeconomy by enabling scalable, secure, cost-effective regenerative manufacturing of cells, tissues and organs through technology development, standards, workforce programs and public-private partnerships.
A $13,047,812 grant to BETA Technologies Inc in 2025 is the largest recent award on file for Advanced Regenerative Manufacturing Institute Inc, and it points to how the institute uses grant funding to move regenerative manufacturing toward scale. The organization backs technology development, process and quality systems, standards work, workforce programs, and commercialization support across the U.S. bioeconomy. Its recent awards also show repeated support for manufacturing-oriented partners such as DEKA Integrated Solutions Corp in Manchester, NH, which received multiple grants across 2023 and 2024, including a $4,163,867 award tied to a CARES Act funded program and a $1,088,937 award in 2025. Another major recipient is MxD USA in Chicago, IL, which appears in multiple years as well, including 2023, 2024, and 2025 grants. The institute’s grantmaking is tied to member-driven project calls, RFPs, and directed subawards, with a pattern of funding projects that address technical gaps in biofabrication, advanced biomanufacturing, and translational infrastructure. Across the recent record, it supports universities, startups, hospitals, and manufacturers working on cells, tissues, organs, and enabling technologies.
In biomanufacturing and technology development, Advanced Regenerative Manufacturing Institute Inc funded X-Therma in San Pablo, CA with $632,120 in 2023 through a technology investment agreement with the government, and it awarded $489,766 that same year to Organamet Bio in Montgomery, AL under the same structure. For translational research and clinical collaboration, it gave Massachusetts General Hospital in Boston, MA $569,674 in 2025 and previously provided $308,773 to The General Hospital Corporation dba Massachusetts General Hospital in 2023 through the NextFab Bilateral Health Tech Hub Program. In university-based work, the institute supported Dartmouth College in Hanover, NH with $415,319 in 2024 and the University of New Hampshire in Durham, NH with $341,318 in 2025. Workforce development also appears through programs such as the Biofabrication Technician Apprenticeship Program and BioTrek, both focused on biofabrication training and career pathways.
$29.7M
$37.9M
$41.5M
$38.9M
Most grants fall between $58K and $240K, with a median of $138K.
25th Percentile
$58K
Median
$138K
75th Percentile
$240K
Maureen Toohey
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Typical award size sits at $57,768 at the 25th percentile, $138,441 at the median, and $239,870 at the 75th percentile. The recent record also shows a mix of one-off and repeated relationships: BETA Technologies Inc, DEKA Integrated Solutions Corp, MxD USA, Massachusetts General Hospital, Dartmouth College, and the University of Florida each appear more than once across different years. Advanced Regenerative Manufacturing Institute Inc is a member-based nonprofit institute, and the grant record reflects restricted, project-specific funding through project calls, RFPs, subawards, and partnership-based programs. The organization’s active programs also indicate that some funding is open to unsolicited proposals.
The grant record is national, with all listed recipient-country activity in the United States. Texas is the top state by grant count, while New Hampshire accounts for 16% of grants. Recent recipients span South Burlington, VT; Chicago, IL; Boston, MA; Hanover, NH; and Durham, NH. The pattern also includes recipients in California, Florida, and Washington, showing that the institute funds across multiple regions rather than concentrating only near Manchester.
Its active programs and recent grants point to biofabrication, regenerative medicine, advanced biomanufacturing, standards and measurement, regulatory and translational work, startup acceleration, and workforce development. The recent record includes awards to manufacturers, universities, hospitals, and startups working on cells, tissues, organs, process development, and commercialization.
Yes. Workforce development appears in both program design and grant activity, including the Biofabrication Technician Apprenticeship Program, BioTrek, and the Elevate NH student loan repayment program in New Hampshire. Recent awards also include university and industry partners tied to training and capacity building.
The grant size distribution centers on a $138,441 median, with a 25th percentile of $57,768 and a 75th percentile of $239,870. The recent record also includes much larger project awards, such as a $13,047,812 grant in 2025.
Its grantmaking is national, with all listed recipients in the United States. Texas is the top state by grant count, and New Hampshire represents 16% of grants. Recent recipients include organizations in South Burlington, Chicago, Boston, Hanover, and Durham.
Yes. Several recipients appear across multiple years, including BETA Technologies Inc, DEKA Integrated Solutions Corp, MxD USA, Massachusetts General Hospital, Dartmouth College, and the University of Florida. That pattern suggests repeated, project-based relationships rather than a single one-time award.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Current and upcoming funding from Advanced Regenerative Manufacturing Institute that your nonprofit may be able to apply for.
Who can apply: Not specified on the scraped page. BioFabUSA is a public-private partnership and future project calls are aligned with the Universal Roadmap; opportunities are shared through member portal and ARMI communication channels.
Deadline: Future project calls aligned with the Universal Roadmap will be announced through the member portal and ARMI communication channels.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| BETA Technologies Inc | South Burlington, VT | $13,047,812 | 2025 | See Part IV |
| DEKA Integrated Solutions Corp | Manchester, NH | $4,163,867 | 2025 | BiofabUSA CARES Act Funded Program (DOD-Directed) |
| DEKA Integrated Solutions Corp | Manchester, NH | $1,088,937 | 2025 | See Part IV |
| MxD USA | Chicago, IL | $872,244 | 2025 | BioFabUSA CARES Act Funded Program (DoD-Directed) |
| MxD USA | Chicago, IL | $697,991 | 2025 | See Part IV |
| Advanced Solutions Inc | Louisville, KY | $663,432 | 2025 | See Part IV |
| Pluristyx | Seattle, WA | $643,723 | 2025 | See Part IV |
| X-Therma | San Pablo, CA | $632,120 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Massachusetts General Hospital | Boston, MA | $569,674 | 2025 | See Part IV |
| Washington University | St Louis, MO | $497,249 | 2025 | Subaward pursuant to our grant with a private foundation |
| Organamet Bio | Montgomery, AL | $489,766 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| University of Florida | Atlanta, GA | $378,792 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| University of New Hampshire | Durham, NH | $341,318 | 2025 | See Part IV |
| Terasaki Institute for Biomedical Innovat | Los Angeles, CA | $316,224 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| The General Hospital Corporation dba Massachusetts General Hospital | Boston, MA | $308,773 | 2025 | NextFab Bilateral Health Tech Hub Program (HHS-Directed) |
| DEKA Research & Development Corp | Manchester, NH | $254,829 | 2025 | NextFab Bilateral Health Tech Hub Program (HHS-Directed) |
| DEKA Integrated Solutions Corp | Manchester, NH | $224,911 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Arizona State University | Tempe, AZ | $215,188 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Boston University | New York, NY | $213,111 | 2025 | See Part IV |
| Dartmouth College | Hanover, NH | $211,116 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| University of California Davis | Los Angeles, CA | $206,863 | 2025 | See Part IV |
| Applied Biosensors | Salt Lake City, UT | $176,723 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Epibone | Jersey City, NJ | $176,564 | 2025 | See Part IV |
| Rutgers University | Piscataway, NJ | $171,757 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Georgia Tech Research Corp | Atlanta, GA | $170,659 | 2025 | See Part IV |
| University of Virginia | Charlottesville, VA | $155,369 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Southwest Research Institute | San Antonio, TX | $152,101 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Arizona State University | Tempe, AZ | $151,108 | 2025 | See Part IV |
| Sudhin Biopharma Co | Superior, CO | $150,341 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Georgia Tech Research Corp | Atlanta, GA | $141,509 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Dartmouth College | Hanover, NH | $137,379 | 2025 | See Part IV |
| Cornell University - Biomedical Eng | Ithaca, NY | $132,438 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Axogen Corp | Alachua, FL | $131,376 | 2025 | See Part IV |
| Applied Biosensors | Salt Lake City, UT | $130,904 | 2025 | See Part IV |
| Sudhin Biopharma Co | Superior, CO | $125,934 | 2025 | See Part IV |
| Trailhead Biosystems Inc | Beachwood, OH | $115,177 | 2025 | See Part IV |
| INCELL | San Antonio, TX | $94,001 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Cell X | Woburn, MA | $92,049 | 2025 | See Part IV |
| Biogen MA Inc | Cambridge, MA | $89,610 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Stratatech Corp Mallinckrodt Pharm | Hazelwood, MO | $83,644 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| University of New Hampshire | Durham, NH | $77,554 | 2025 | See Part IV |
| University of Notre Dame (ND) | Notre Dame, IN | $74,782 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Standards Coordinating Body | Gaithersburg, MD | $68,720 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| WPI | Worcester, MA | $63,843 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Brown Univerisity | Providence, RI | $63,629 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Regenerative Patch Technologies | Portola Valley, CA | $61,065 | 2025 | See Part IV |
| Axogen Corp | Alachua, FL | $57,893 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| Blood Cell Storage Inc | Seattle, WA | $57,643 | 2025 | Subaward pursuant to our Technology Investment Agreement with the Government |
| DEKA Integrated Solutions Corp | Manchester, NH | $56,745 | 2025 | See Part IV |
| Auburn University | Auburn, AL | $47,707 | 2025 | See Part IV |
BETA Technologies Inc
$13,047,812See Part IV
DEKA Integrated Solutions Corp
$4,163,867BiofabUSA CARES Act Funded Program (DOD-Directed)
DEKA Integrated Solutions Corp
$1,088,937See Part IV
MxD USA
$872,244BioFabUSA CARES Act Funded Program (DoD-Directed)
MxD USA
$697,991See Part IV
Advanced Solutions Inc
$663,432See Part IV
Pluristyx
$643,723See Part IV
X-Therma
$632,120Subaward pursuant to our Technology Investment Agreement with the Government
Massachusetts General Hospital
$569,674See Part IV
Subaward pursuant to our grant with a private foundation
Organamet Bio
$489,766Subaward pursuant to our Technology Investment Agreement with the Government
University of Florida
$378,792Subaward pursuant to our Technology Investment Agreement with the Government
University of New Hampshire
$341,318See Part IV
Terasaki Institute for Biomedical Innovat
$316,224Subaward pursuant to our Technology Investment Agreement with the Government
The General Hospital Corporation dba Massachusetts General Hospital
$308,773NextFab Bilateral Health Tech Hub Program (HHS-Directed)
DEKA Research & Development Corp
$254,829NextFab Bilateral Health Tech Hub Program (HHS-Directed)
DEKA Integrated Solutions Corp
$224,911Subaward pursuant to our Technology Investment Agreement with the Government
Arizona State University
$215,188Subaward pursuant to our Technology Investment Agreement with the Government
Subaward pursuant to our Technology Investment Agreement with the Government
University of California Davis
$206,863See Part IV
Applied Biosensors
$176,723Subaward pursuant to our Technology Investment Agreement with the Government
Epibone
$176,564See Part IV
Rutgers University
$171,757Subaward pursuant to our Technology Investment Agreement with the Government
Georgia Tech Research Corp
$170,659See Part IV
University of Virginia
$155,369Subaward pursuant to our Technology Investment Agreement with the Government
Subaward pursuant to our Technology Investment Agreement with the Government
Arizona State University
$151,108See Part IV
Sudhin Biopharma Co
$150,341Subaward pursuant to our Technology Investment Agreement with the Government
Georgia Tech Research Corp
$141,509Subaward pursuant to our Technology Investment Agreement with the Government
Subaward pursuant to our Technology Investment Agreement with the Government
Axogen Corp
$131,376See Part IV
Applied Biosensors
$130,904See Part IV
Sudhin Biopharma Co
$125,934See Part IV
Trailhead Biosystems Inc
$115,177See Part IV
INCELL
$94,001Subaward pursuant to our Technology Investment Agreement with the Government
Cell X
$92,049See Part IV
Biogen MA Inc
$89,610Subaward pursuant to our Technology Investment Agreement with the Government
Stratatech Corp Mallinckrodt Pharm
$83,644Subaward pursuant to our Technology Investment Agreement with the Government
University of New Hampshire
$77,554See Part IV
Subaward pursuant to our Technology Investment Agreement with the Government
Standards Coordinating Body
$68,720Subaward pursuant to our Technology Investment Agreement with the Government
Subaward pursuant to our Technology Investment Agreement with the Government
Subaward pursuant to our Technology Investment Agreement with the Government
Regenerative Patch Technologies
$61,065See Part IV
Axogen Corp
$57,893Subaward pursuant to our Technology Investment Agreement with the Government
Blood Cell Storage Inc
$57,643Subaward pursuant to our Technology Investment Agreement with the Government
DEKA Integrated Solutions Corp
$56,745See Part IV
Auburn University
$47,707See Part IV